NASDAQ: OMER       Omeros Corp
Last Price Today's Change   Day's Range   Trading Volume
2.66   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):1,396,138
4 Weeks Range:1.85 - 3.05
4 Weeks Price Volatility (%):
52 Weeks Range:1.85 - 16.57
52 Weeks Price Volatility (%):
Average Price Target: 30.00
Price Target Upside/Downside: +27.34


No recent Headlines for this stock.

Business Background

Omeros Corp is a United States based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2730  1602  236  7743 

Top 10 Active Counters
 ISBC 13.87-0.35 
 DIDI 2.29-0.07 
 ENDP 0.423-0.10 
 AMD 77.275-0.715 
 AMZN 105.87-3.05 
 CCL 8.485-0.385 
 AAPL 136.74-2.49 
 CERN 94.920.00 
 NVDA 153.328-2.092 
 NIO 21.60-0.26